Literature DB >> 18559276

Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription.

Elaine Waldron1, Simone Isbert, Andreas Kern, Sebastian Jaeger, Anne M Martin, Sébastien S Hébert, Christian Behl, Sascha Weggen, Bart De Strooper, Claus U Pietrzik.   

Abstract

A sequence of amyloid precursor protein (APP) cleavages culminates in the sequential release of the APP intracellular domain (AICD) and the amyloid beta peptide (Abeta) and/or p3 fragment. One of the environmental factors favouring the accumulation of AICD appears to be a rise in intracellular pH. Here we further identified the metabolism and subcellular localization of artificially expressed constructs under such conditions. We also co-examined the mechanistic lead up to the AICD accumulation and explored possible significances for its increased expression. We found that most of the AICD generated under pH neutralized conditions is likely cleaved from C83. While the AICD surplus was unable to further activate transcription of a luciferase reporter via a Gal4-DNA-binding domain, it failed entirely via the endogenous promoter regions of proposed target genes, APP and KAI1. The lack of a specific transactivation potential was also demonstrated by the unchanged levels of target gene mRNA. However, rather than translocating to the nucleus, the AICD surplus remains membrane tethered or free in the cytosol where it interacts with Fe65. Therefore we provide strong evidence that an increase in AICD generation does not directly promote gene activation of previously proposed target genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559276     DOI: 10.1016/j.yexcr.2008.05.003

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

Review 1.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

Review 2.  RIP at the Synapse and the Role of Intracellular Domains in Neurons.

Authors:  Yan Jun Lee; Toh Hean Ch'ng
Journal:  Neuromolecular Med       Date:  2019-07-25       Impact factor: 3.843

Review 3.  The vexing complexity of the amyloidogenic pathway.

Authors:  Manuel A Castro; Arina Hadziselimovic; Charles R Sanders
Journal:  Protein Sci       Date:  2019-04-11       Impact factor: 6.725

Review 4.  Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.

Authors:  Gerhard Multhaup; Otmar Huber; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2015-08-21       Impact factor: 5.157

5.  Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking.

Authors:  Timo Sarajärvi; Jussi T Tuusa; Annakaisa Haapasalo; Jarkko J Lackman; Raija Sormunen; Seppo Helisalmi; Johannes T Roehr; Antonio R Parrado; Petra Mäkinen; Lars Bertram; Hilkka Soininen; Rudolph E Tanzi; Ulla E Petäjä-Repo; Mikko Hiltunen
Journal:  Mol Cell Biol       Date:  2011-04-04       Impact factor: 4.272

Review 6.  The many substrates of presenilin/γ-secretase.

Authors:  Annakaisa Haapasalo; Dora M Kovacs
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Inhibitors of γ-secretase stabilize the complex and differentially affect processing of amyloid precursor protein and other substrates.

Authors:  Gael Barthet; Junichi Shioi; Zhiping Shao; Yimin Ren; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  FASEB J       Date:  2011-05-19       Impact factor: 5.191

Review 8.  Physiological functions of APP family proteins.

Authors:  Ulrike C Müller; Hui Zheng
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

9.  The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?

Authors:  N N Nalivaeva; N D Belyaev; I A Zhuravin; A J Turner
Journal:  Int J Alzheimers Dis       Date:  2012-07-26

10.  Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21).

Authors:  R B Cejas; M Tamaño-Blanco; J G Blanco
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.